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Abstract
Background: Ventriculoperitoneal (VP) shunt insertion remains the mainstay of
treatment for hydrocephalus despite a high rate of complications. The predictors of
shunt malfunction have been studied mostly in pediatric patients. In this study, we
report our 11‑year experience with VP shunts in adult patients with hydrocephalus.
We also assess the various factors affecting shunt survival in a developing country
setting.
Methods: A retrospective chart analysis was conducted for all adult patients who
had undergone shunt placement between the years 2001 and 2011. Kaplan–Meier
curves were used to determine the duration from shunt placement to first malfunction
and log‑rank (Cox–Mantel) tests were used to determine the factors affecting shunt
survival.
Results: A total of 227 patients aged 18–85 years (mean: 45.8 years) were
included in the study. The top four etiologies of hydrocephalus included
post‑cranial surgery (23.3%), brain tumor or cyst (22.9%), normal pressure
hydrocephalus (15%), and intracranial hemorrhage (13.7%). The overall incidence
of shunt malfunction was 15.4% with the median time to first shunt failure being
120 days. Etiology of hydrocephalus (P = 0.030) had a significant association with
the development of shunt malfunction. Early shunt failure was associated with
age (P < 0.001), duration of hospital stay (P < 0.001), Glasgow Coma Scale (GCS)
score less than 13 (P = 0.010), excision of brain tumors (P = 0.008), and placement
of extra‑ventricular drains (P = 0.033).
Conclusions: Patients with increased age, prolonged hospital stay, GCS score
of less than 13, extra‑ventricular drains in situ, or excision of brain tumors were
more likely to experience early shunt malfunction.
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INTRODUCTION
Ventriculoperitoneal (VP) shunt placement is the
mainstay of treatment for hydrocephalus in both adult

and pediatric patients.[2,5,28,33,43] In the United States alone,
more than 30,000 procedures to relieve hydrocephalus are
performed every year.[4,24] Despite this fact, VP shunting
remains vulnerable to a number of complications. The
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1‑year failure rate for VP shunts had been reported at
around 40-50% for pediatric patients and 29% for adults
until a few decades ago.[5,6,18,40] More recent studies report
a relatively lower rate of shunt failure, though it still
remains substantial.[15,32,33,38,42]
VP shunt malfunction remains the most frequent reason
for shunt revisions.[5,6,26,27,38] Although shunt failure
has been studied extensively, most of the studies have
addressed pediatric patients, and very little has been
published on adult patients.[6,14,20,34,42] Moreover, many
of these studies are from developed countries, which
theoretically have only limited application to developing
countries by virtue of the difference in etiologies.[9,16,41]
Hereby, we report an 11‑year experience of managing
adult hydrocephalus, including etiologies of disease,
patient demographics, shunt survival and failure rate, and
causes of shunt malfunction.

MATERIALS AND METHODS
We performed a retrospective chart review using our
inpatient database. Files were retrieved using International
Classification of Diseases, 9th Revision‑Clinical
Modification (ICD‑9‑CM) codes for “hydrocephalus” and
“ventriculoperitoneal shunt.” Adult patients were defined
as those who were 18 years of age or older. Each file was
individually reviewed for various details such as patient
demographics, presentation, neurological examination,
laboratory and radiological investigations, medical and
surgical management, hospital stay, follow‑up, and
further management. Follow‑up in neurosurgery clinics
was specifically reviewed for periodic shunt assessment,
persistent or new onset symptoms, and any neurological
deficits in terms of visual symptoms and motor and
cognitive deficits. In case of shunt malfunction, cause
and delay from first insertion to revision were also
studied. Any and all further hospital admissions and
surgeries were also studied.
Types of hydrocephalus we identified included
normal pressure hydrocephalus (NPH), obstructive
hydrocephalus, idiopathic hydrocephalus (etiology
unknown), and communicating hydrocephalus, as
previously reported by Reddy et al.[33] NPH at our center
was diagnosed through a standard protocol involving gait
and memory assessment pre‑ and post‑diagnostic lumbar
drainage. This assessment involved the consultation
of a neurologist as well as a physical therapist.
Communicating hydrocephalus was the diagnosis
reserved for high‑pressure hydrocephalus without an
obvious obstructive pathology involving the ventricular
system, although there might have been impairment in
cerebrospinal fluid (CSF) absorption. Etiologies were
grouped into different categories, which was slightly
modified from Reddy et al.[33] and Mori et al.,[22] and
included NPH, infectious or post‑infectious (bacterial
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meningitis or abscess, and tuberculous meningitis),
infarcts, brain tumor/colloid and other types of
cysts, subarachnoid hemorrhage (SAH), post‑cranial
surgery, aneurysm or vascular malformation, and
intracranial hemorrhage (other than SAH, but including
intraventricular and intracerebral hemorrhages).[22,29,33]
Post‑cranial surgery hydrocephalus is a unique subset
of hydrocephalus that develops in patients following
a cranial surgery.[10,21,39] It is believed to result from
a combination of iatrogenic damage that occurred
during the surgical procedure to the cells of the
choroid plexus[11,21] and the alterations occurring
postoperatively in the CSF circulation, cerebral blood
flow auto‑regulation, and cerebral compliance.[39] Other
etiologies included shunt malfunction (infection or
blockage) presenting to us with known or unknown
etiology, idiopathic, Arnold–Chiari or Dandy–Walker
malformations, and traumatic brain injury (TBI).
The primary outcome of interest of this retrospective
clinical study was shunt survival and revision rate. Causes
of shunt failure were also determined. Shunt failure
was defined as by Reddy et al.[33] and categorized as
shunt infection, blockage and migration, CSF ascites,
or shunt failure caused by an unknown factor. All these
shunt complications led to shunt revision.
Data were recorded on a pre‑tested proforma. Statistical
procedures included frequency determination, mean
and standard deviation, and Pearson’s Chi‑square test
for comparison of proportions. The Student’s t‑test
and independent sample t‑test or the Mann–Whitney
U test was used for comparison of means or medians,
respectively. For all comparisons, a P < 0.05 was considered
statistically significant. Kaplan–Meier curves were used
to determine duration from shunt placement to first
malfunction. The log‑rank (Mantel–Cox) test was used to
determine the factors affecting shunt survival. Data entry
and statistical analysis were performed on Statistical Package
for Social Sciences version 19 (IBM SPSS Statistics 19,
IBM Corporation, Chicago, Illinois).

RESULTS

Patient demographics

A total of 319 patients underwent VP shunt placement
during the 11‑year period. The total number of all types of
neurosurgical procedures carried out at our center during
the same time period was approximately 13,000. These
VP shunt procedures were performed by seven different
neurosurgeons. Pressure‑controlled shunts (Medtronic)
were used in all cases at a medium pressure in most
cases; these shunts have a distal valve located within the
pump and cost about US $240 in Pakistan.
Out of the 319 patients identified initially, 92 were
excluded because of the unavailability of medical
records [Figure 1]. The mean age of patients
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included in our study was 45.8 years, ranging from a
minimum of 18 years to a maximum of 85 years. One
hundred and fifty‑one (66.5%) patients were male,
and hypertension (n = 161, 70.9%) and diabetes
mellitus (n = 30, 13.2%) were the most common
co‑morbid conditions [Table 1].

Etiologies and clinical manifestations

The etiologies of hydrocephalus in our patients
included post‑cranial surgery (n = 53, 23.3%),
brain tumor or cyst (n = 52, 22.9%), NPH (n = 34,
15%), hemorrhage (n = 31, 13.7%), tuberculous
meningitis (n = 9, 4.0%), bacterial meningitis or brain
abscess (n = 2, 0.9%), and others (n = 46, 20.3%). Other
etiologies included shunt malfunction (n = 16, 7%),
TBI (n = 13, 5.7%), post‑meningitis (n = 14, 6.2%),
Adult Hydrocephalus Patients with
Ventriculoperitoneal Shunts
(n = 319)

Arnold–Chiari or Dandy–Walker malformation (n = 8,
3.5%), and idiopathic (n = 7, 3.1%), as given in Table 2.
Some patients had more than one etiology contributing
to the development of hydrocephalus. Furthermore, all
the patients who presented with shunt malfunction as
etiology had undergone VP shunt placement in the past
outside our center.
Of the 31 (13.7%) patients with intracranial hemorrhage
as an etiology, 23 (10.1%) had SAH, 6 (2.6%) had
intraparenchymal hemorrhage, and 2 (0.9%) had
subdural hematoma. Among patients with brain
tumors (n = 52, 22.9%), extra‑axial tumors (n = 30,
13.2%) were more common than intra‑axial tumors
(n = 22, 9.7%). Meningioma or oligodendroglioma
(n = 12, 5.3%), vestibular schwannoma (n = 10, 4.4%),
and hemangioblastoma or hemangioma (n = 7, 3.1%)
were the most common. Posterior cranial fossa (n = 16,
Table 1: Demographics (N=227)
Characteristics

Excluded
(n = 92)

Patients included in the final analysis
(n = 227)

Etiology
Post-Cranial Surgery
Brain Tumor or cyst
NPH
Hemorrhage
Meningitis
Others

Type
53
52
34
31
11
46

Obstructive
Normal Pressure
Communicatin
Idiopathic

155
39
25
8

Shunt Malfunction
(n = 35)
Shunt blockade
25
Shunt Infection
7
Shunt migration
3
CSF Ascites
2
(Some patients had more than one
type of shut malfunction)
Ventriculoperitoneal
shunts Revisions
(n = 27)

Revision within 6 months
(n = 19)

Revision after 6 months
(n = 8)

Figure 1: Illustrating the inclusion and exclusion of patient records
for analysis in this study and a summary of the various etiologies
and types of hydrocephalus with subsequent ventriculoperitoneal
shunt procedures. NPH: Normal pressure hydrocephalus

n (%)

Sex
Male
Female
Age (>17 years)
Mean age
Young (18-40 years)
Middle‑aged (40-65 years)
Elderly (>65 years)
Co‑morbidities
Hypertension
Diabetes mellitus
Ischemic heart disease

151 (66.5)
76 (33.5)
45.8±1.1 years
90 (39.6)
89 (39.2)
48 (21.1)
161 (70.9)
30 (13.2)
7 (3.1)

Table 2: Etiologies of hydrocephalus with
malfunction (P<0.05)
Etiology

Patients
(N=227)*
(%)

Patients with
shunt malfunction
(n=35) (%)

Post‑cranial surgery
Brain tumor
Normal pressure hydrocephalus
Hemorrhage
Shunt malfunction†
Post‑meningitis hydrocephalus
Traumatic brain injury
Tuberculous meningitis
Arnold-Chiari/Dandy-Walker
malformation
Idiopathic
Bacterial meningitis
Infarction or stroke

53 (23.3)
52 (22.9)
34 (15.0)
31 (13.7)
16 (7)
14 (6.2)
13 (5.7)
9 (4.0)
8 (3.5)

7 (13.21)
9 (17.31)
3 (8.82)
1 (3.23)
2 (12.50)
3 (21.43)
2 (15.38)
2 (22.22)
4 (50.00)

7 (3.1)
2 (0.9)
1 (0.4)

1 (14.28)
0 (0)
1 (100)

*Some patients had more than one etiology of hydrocephalus, †These patients had
undergone ventriculoperitoneal shunt placement in the past outside our center and
presented to us with shunt malfunction
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7.0%), cerebellopontine angle (n = 15, 6.6%) and supra‑ or
parasellar (n = 9, 4.0%) region were the most common sites
for tumors. The types of hydrocephalus were obstructive
hydrocephalus (n = 155, 68.3%), NPH (n = 39, 17.2%),
communicating hydrocephalus (n = 25, 11.0%), and
idiopathic (n = 8, 3.5%) [Table 3]. Among patients with
brain tumors (n = 52, 22.9%), most (n = 50, 22.0%)
had obstructive hydrocephalus, while only two (3.9%)
had communicating hydrocephalus secondary to choroid
plexus papillomata. The relevant past medical and
surgical history of our study subjects is summarized in
Table 4.
Symptoms at the time of presentation included
headache (n = 101, 44.5%), drowsiness or
altered consciousness (n = 91, 40.1%), gait
disturbances
(n
=
89,
39.2%),
nausea
or
vomiting (n = 69, 30.4%), weakness (n = 52, 22.9%),
urinary or fecal incontinence (n = 44, 19.4%), decline
in memory (n = 26, 11.4%), visual abnormality (n = 26,
11.4%), fever (n = 25, 11.0%), and seizures (n = 22,
9.7%). On presentation, the Glasgow Coma Scale (GCS)
score of patients ranged from 3 to 15, with a mean of 12
and a median of 14. Twenty‑six (11.4%) patients were
comatose (GCS ≤ 8) on presentation, while GCS score
was less than 13 in all patients with drowsiness (n = 91,
40.1%). Motor deficits were found in 99 (43.6%) patients.
Laboratory investigations in these patients included serum
chemistry, blood counts, blood culture, and radiological
investigations. Lumbar puncture was performed in
116 (51.1%) patients.
Table 3: Types of hydrocephalus with malfunction (P=0.726)
Type of hydrocephalus
(N=227)
Obstructive hydrocephalus
Normal pressure hydrocephalus
Communicating hydrocephalus
Idiopathic

n (%)

Patients with shunt
malfunction (n=35)

155 (68.3)
39 (17.2)
25 (11.0)
8 (3.5)

25 (16.13)
4 (10.26)
5 (20.00)
1 (12.50)

Depending on the clinical condition of patients, they were
managed in general ward, special care units, or intensive
care units. The mean duration of hospital stay was
13.6 ± 1.1 days. One hundred and ninety‑five (85.9%)
of the patients received antibiotics. Mannitol was
administered to 28 (12.3%) patients, while only 9 (4.0%)
patients
received
acetazolamide.
Anticonvulsants
and steroids were used in 57 (25.1%) and 51 (22.5%)
patients, respectively. Nine (4.0%) patients also received
anti‑tuberculous therapy.
Surgical management of the patients other than VP shunt
placement included extra‑ventricular drains (n = 43,
18.9%), craniotomy or craniectomy (n = 31,
13.7%), clipping of aneurysm (n = 12, 5.3%),
ventriculostomy (n = 5, 2.2%) and other procedures. All
the patients included in this study underwent VP shunt
placement. Two hundred (88.1%) patients underwent VP
shunt placement only once, while 27 (11.9%) patients
required revision of the malfunctioned shunt later
on. Of these patients, four (1.8%) required revision of
the malfunctioned shunt during the same admission.
A right‑sided shunt was placed in 209 (92.1%) patients,
while the remaining 18 (7.9%) patients received a
left‑sided shunt.

Clinical follow‑up

Only 161 (70.9%) patients followed up regularly; rest of
the patients (n = 66, 29.1%) were lost to follow‑up after
the first postoperative clinic visit. The mean duration of
follow‑up was 321.6 days. Twelve (5.3%) patients died,
most of whom (n = 10, 4.4%) died within a month
after surgery. The remaining two patients (0.9%) died
2 months and 10 months post‑surgery, respectively.
Cardiac arrest (n = 3, 1.3%), brain‑stem death (n = 2,
0.9%), and pulmonary embolism (n = 1, 0.4%) were the
known causes of death in these patients. The exact cause
of death in the remaining cases was not known.

Shunt complications

Table 4: Past medical and surgical history of study
subjects (N=227)
Past history
Mass lesion
Meningitis
Hydrocephalus
Head injury
Subarachnoid hemorrhage
Types of interventions
Surgery for mass lesion
Ventriculoperitoneal shunt placement
Received antibiotics for meningitis
Anti‑tuberculous drugs

Management

n

%

47
25
24
15
14

20.7
11.0
10.6
6.6
6.2

53
24
19
17

23.3
10.6
8.4
7.5

The incidence of overall shunt malfunction was found
to be 15.4%, while the incidence of shunt revision was
14.1%. Kaplan–Meier curve showed that shunt failure
rates at 6 months, 1 year, and 6 years were 19/227 (8.4%),
25/227 (11.0%), and 35/227 (15.4%), respectively. The
most common causes of shunt malfunction were shunt
blockade (n = 25, 11.0%), shunt infection (n = 8, 3.5%),
shunt migration (n = 2, 0.9%), and CSF ascites (n = 2,
0.9%) [Table 5]. Of the 35 patients who experienced
shunt malfunction, two patients suffered both shunt
blockage and shunt infection. The development of shunt
malfunction was significantly influenced by the principal
etiology of the hydrocephalus (P = 0.030). Of 74 patients
with brain tumors – some of which were post‑excision and
the rest were diagnosed during admission – 10 patients
had shunt malfunction (P = 0.580). Nine of these patients
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Table 5: Complications of ventriculoperitoneal shunt*
Complication type

n (%)

Shunt blockage
Shunt infection
Shunt migration
Shunt CSF ascites

25 (11)
7 (3.5)
3 (1.3)
2 (0.9)

CSF: Cerebrospinal fluid, *Two patients experienced both shunt blockage and shunt
infection

Table 6: Factors affecting shunt malfunction (N=227)
Factors
Demographics
Sex
Age
Comorbid
conditions
Past medical and
surgical history
Meningitis
Hydrocephalus
Head injury
Stroke/SAH
Mass lesion
Antibiotics
Anti‑tuberculosis
drugs
VP shunt
Surgical repair

P*
0.503
0.298
0.229

Factors
Management
Hospital care unit
Duration of hospital stay
Antibiotics given
Mannitol

P*
0.601
0.249
0.470
0.067

0.193
0.356
0.822
0.997
0.810
0.133
0.137

Diamox
Steroids
Anticonvulsants
Anti‑tuberculosis drugs
Surgical intervention
Type of surgical intervention
Extra‑ventricular drain

0.802
0.962
0.391
0.283
0.994
0.001
0.445

0.160
0.665

Side of VP shunt placement
Number of revisions
KPS

0.507
<0.001
0.364

SAH: Subarachnoid hemorrhage,VP:Ventriculoperitoneal, KPS: Karnofsky performance
score, *P value for qualitative and quantitative variables based on Pearson
Chi‑square (χ2) test and Mann-Whitney U test, respectively
Factors having a statistically significant association with shunt malfunction are shown
in bold.

Figure 2: Kaplan–Meier shunt survival analysis for adult hydrocephalus
shows overall median time to first shunt failure was 120 days.
Shunt survival time ranged from 0 to 2095 days. Out of 35 shunt
malfunctions, 30 occurred before 500 days

underwent shunt revision. Out of 53 post‑cranial surgery
patients, only 7 developed shunt malfunction (P = 0.611)
and all of them had shunt revision. Of 34 patients with
NPH, 3 developed shunt malfunction (P = 0.248);
shunt revision was performed in all of them. Amongst
31 patients with hemorrhage, only 1 patient had shunt
malfunction and required shunt revision (P = 0.043).
Shunt malfunction was not found to have a significant
impact on the overall functional outcome of
patients (P = 0.364) [Table 6]. Among elderly patients,
causes of shunt failure included shunt blockage (n = 2),
shunt migration (n = 2), and shunt infection (n = 1).

Factors affecting time to first shunt failure (VP
shunt survival)

Overall median time from shunt placement to
shunt malfunction was 120 days, ranging from 2 to
2095 days [Figure 2]. Kaplan–Meier plot showed that
the median time from shunt placement to first shunt
failure was significantly different among all individuals in
principal etiologies (P = 0.003, log‑rank test) [Figure 3].
Individuals with intracranial hemorrhage, brain tumor,
post‑cranial surgery, and NPH showed a shortest shunt
survival to first shunt failure. Median time to VP shunt
failure did not differ significantly between the different
types of hydrocephalus (P = 0.174, log‑rank test). Patients’
gender did not show significant statistical difference
in median time from shunt placement to first shunt
failure between male and female individuals (P = 0.671,
log‑rank test) or medical co‑morbidities (P = 0.701,
log‑rank test). Time to first shunt failure for elderly
patients was significantly lower than that for other
patients (P < 0.001, log‑rank test), ranging between 4
and 120 days. Duration of hospital stay was statistically
significant for median time to shunt failure (P < 0.001,
log‑rank test). Difference in median time from shunt

Figure 3: Kaplan–Meier shunt survival analysis for adult hydrocephalus
shows that etiologies of hydrocephalus significantly differed in median
time to first shunt failure (P = 0.003, log-rank test). NPH: Normal
pressure hydrocephalus, SAH: Subarachnoid hemorrhage
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placement to first shunt failure between the different
types of brain tumor (P = 0.062, log‑rank test) and the
different locations of brain tumor (P = 0.378, log‑rank
test) failed to reach statistical significance. Past medical
history of the patient did not significantly affect the
median time of shunt survival.
Patients who had a GCS score of less than 13 were
found to experience early shunt failure (P = 0.010,
log‑rank test) as shown in Figure 4. Similarly, drowsiness
or altered consciousness on presentation was found to
have a significant effect on shunt survival (P = 0.010,
log‑rank test). This adverse impact of drowsiness or
altered consciousness on the medial shunt failure time
was independent of the etiology of hydrocephalus.
Median shunt survival time was found to be significantly
different between patients who underwent different types
of surgical interventions other than VP shunt (P = 0.044,
log‑rank test). Similarly, median shunt survival time was
also found to be significantly affected by the placement of
extra‑ventricular drains (P = 0.033, log‑rank test) before
VP shunt [Figure 5]. Side of shunt (P = 0.882, log‑rank
test), hospital care units (P = 0.171, log‑rank test), and
physiotherapy (P = 0.203, log‑rank test) were not found to
have any significant effect on medial shunt survival time.

DISCUSSION
Despite the fact that CSF diversion with VP shunt
placement has been the mainstay of management in both
pediatric and adult hydrocephalus, VP shunts still have
noteworthy complications and failure rate.[8,19] The periodic
evaluation of patients who are managed with VP shunt
placement for hydrocephalus cannot be overlooked. By
studying the patterns of shunt survival extensively, one can
attempt to predict the behavior of VP shunt functioning
from the time of placement to subsequent follow‑up.

Figure 4: Kaplan–Meier shunt survival analysis for adult hydrocephalus
shows that patients with a GCS score of less than 13 were more
likely to experience early shunt failure (P = 0.010, log-rank test)

http://www.surgicalneurologyint.com/content/6/1/25

Demographics, such as age, gender, and co‑morbid
conditions, did not upset the shunt function overall, but
median time to shunt malfunction was severely affected
by extreme of age. This might be accounted for by the
fact that elderly patients have fragile and atrophic brain
parenchyma. Surgical intervention in such patients
was probably associated with a higher risk of iatrogenic
trauma inflicted to the nearby tissues while placing the
VP shunt. Injury to cells of the choroid plexus within
the ventricles could lead to the accumulation of cellular
debris within the catheter and clog the tubing of the
VP shunt, resulting in shunt blockage.[32] Although this
explanation seems plausible theoretically, it cannot be
said with certainty that this was the actual reason for
early shunt failure in elderly patients in our cohort.
Another peculiar observation of our study was a slight
predominance of male patients (66.5%) as opposed to
female patients (33.5%), which is in line with earlier
reports from our region.[13,23,35,36] This might be a
consequence of the male‑dominated structure of the
local society, cultural traditions, and the type of activities
that men are more likely to engage into than women.[23]
Among the etiologies of hydrocephalus, hemorrhage
was found to have a significantly adverse impact on the
functional outcome of patients, which is in line with
observation from earlier studies.[3,7,37] VP shunts in patients
who have experienced intra‑cerebral or intra‑parenchymal
hemorrhage may become clogged with red blood cells
and platelet microthrombi, resulting in shunt blockage.[11]
Similarly, some of the etiologies including intracranial
hemorrhage, brain tumor, post‑cranial surgery, and NPH
were found to have the shortest time to first malfunction.
Development of hydrocephalus following cranial surgery
may be attributed to the damage that occurred to cells

Figure 5: Kaplan–Meier shunt survival analysis for adult hydrocephalus
shows that median time to first shunt failure was significantly
different among patients who underwent extra-ventricular drain
and those who did not (P = 0.033, log-rank test). EVD: Extraventricular drain
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of the choroid plexus and other nearby tissues during
the surgical procedure.[11,26,39] Therefore, theoretically
speaking, the indication for which cranial surgery was
performed, expertise of the operating surgeon, surgical
techniques employed, as well as other patient factors
may also influence the survival of VP shunts inserted in
such patients.[15,20] Likewise, extensive manipulation and
injury to tissues occurring during resection of neoplastic
disease, as well as alterations in cerebral blood flow and
auto‑regulation that occur after the procedure result in
early shunt failure in patients with brain tumors.[31]
In contrast to the etiology of hydrocephalus, the type
of hydrocephalus did not influence overall shunt
malfunction and survival. Albeit previous studies have
not found any association between clinical features and
shunt survival,[30] we observed in our study that patients
with drowsiness and low GCS score on examination had
prominently reduced median time to first shunt failure.
GCS score is an indirect measure of brain functionality
and is often used as a marker of severity of TBI.[41]
Patients who had a low GCS score on presentation were
more likely to have severe abnormalities and pathologies
and, therefore, were at increased risk of experiencing
shunt failure. However, this association between GCS
score and early shunt failure has not been previously
reported. Patients who underwent surgical procedures
other than VP shunt placement, particularly craniectomy
for excision and extra‑ventricular drain placement, had a
decreased median time to first shunt failure. This may
in turn be related to the induction of inflammation and
resultant tissue reaction, resulting in precipitation of
hydrocephalus.[11,20]
Most of the shunt failures occurred within 6 months
post shunt placement, which is compatible with previous
reports from developed countries.[5,6,17,20,25,27,30,33,42] Shunt
obstruction, infection, migration, and CSF ascites
accounted for the most common causes of shunt
malfunction. The above observation is also in accordance
with the previously reported shunt complications.[1,12,25,30]
The VP shunt failure rate reported earlier ranged from
18% to 29% for adult hydrocephalus.[17,20,30,31,42] The overall
VP shunt failure rate (15.4%) that we report is consistent
with the shunt failure rate (15.2%) recently recounted
by Reddy et al.[30] The shunt failure rates at 6 months,
i.e. 19/227 (8.37%), and at 500 days, i.e. 26/227 (11.45%),
are well below the previously reported failure rates. In
another study, Reddy et al. reported 32% incidence of
shunt revision in adult hydrocephalus patients.[33] The
lower shunt failure rate observed in our study was indeed
surprising. Meticulous surgical technique and improved
asepsis might be considered as factors for this lower
rate; however, these factors were not standardized and
assessed properly in this retrospective study. Moreover,
meticulous surgical technique would also be utilized in
other centers, most notably that of Reddy et al.[30] A more
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plausible explanation for this observation could be that
shunt failure typically implies a symptomatic shunt failure
requiring revision. Patients who might become shunt
independent later on would continue to be asymptomatic,
even if their VP shunt was not functioning. Such patients
would not be separately excluded from this definition,
and hence, it might have led to an erroneously low failure
rate. The question that arises here is should a patient
with a failed shunt, but no hydrocephalus, be categorized
as a VP shunt failure? Or should we only consider those
patients who would require a revision to have a failed
VP shunt? This could be considered a loophole in the
definition of shunt failure. In this study, we did not have
information for asymptomatic patients with shunt failure.
Consequently, we did not consider such patients to have
shunt failures. As for the low shunt infection rate in our
study, it is interesting to note that some other studies have
also documented a markedly low rate recently.[9,14,16,26,29]
This study has certain limitations due to its retrospective
design. Results of this study could be affected by technical
factors like different surgeons, and their experience and
preference of surgical methods. Moreover, only those
patients were included in this study whose medical
records were complete and retrievable; this might have
introduced selection bias. Shunt survival in patients who
were excluded due to missing records remains unknown.
Similarly, shunt survival analysis was performed only for
those who were able to follow‑up regularly. A significant
proportion of patients who were either excluded due to
missing data or failed to follow‑up regularly may have
skewed the results of our study.
Despite the aforementioned shortcomings, this study
contributes substantially to the scientific pool of
knowledge. This is the first study from the region to
gather and analyze very detailed data of adult patients
with hydrocephalus undergoing VP shunt placement.
Patients’ past medical and surgical history, etiology
of hydrocephalus, hospital course, and follow‑up in
clinics were extensively studied to find the association
with shunt survival. Although this study reveals a lower
shunt failure rate and a median shunt survival time that
concurs with earlier studies, prospective studies focusing
on periodic evaluation of shunt and functional status
may shed more light on the predictors of shunt survival
and long‑term functional outcome.

CONCLUSIONS
Our study showed that patients undergoing surgical
excision of tumor and patients in whom extra‑ventricular
drains were placed were more likely to have an early
shunt failure. Altered consciousness at presentation (GCS
score of less than 13) was a predictor of decreased shunt
survival time. Shunt survival was also significantly
affected by age and duration of hospital stay.
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